Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2

Overview of attention for article published in Breast Cancer Research, March 2005

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 34 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS

Application EP-3617330-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.